FindTrial
Sign In

Treatment response among bipolar disorder patients

Molecular profiling of A- kinase anchoring protein 11 (AKAP11) and Glycogen synthase kinase - 3 beta (GSK3B) expression and their association with clinical and treatment outcomes among bipolar disorder patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091664
Enrollment
118
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F319- Bipolar disorder, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Nitte University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. BD patients aged between 18 65 years. 2. BD patients or impartial witness willing to participate or provide written informed consent. 3. BD patients presenting with mania / depression / mixed episodes. 4. Newly diagnosed BD patients from the Department of Psychiatry (IPD/OPD patients).

Exclusion criteria

Exclusion criteria: 1. K/C/O Alcohol use disorder (AUD) and K/C/O substance use disorder. 2. Another independent psychiatric disorder (dual diagnosis).

Design outcomes

Primary

MeasureTime frame
Clinical outcomes: Medication adherence and Functional outcomes Treatment outcomes: Mood outcomes and Treatment responseTimepoint: Baseline, 1 months, 2 months and 3 months—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Juno J Joel

KS Hegde Medical Academy

shrinivasabhat@yahoo.co.in9845204136

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026